Pila Pharma AB (publ)
STO: PILA.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gustav Hanghoj Gram
- Employees
- 1
- Headquarters
- Malmö, Sweden
- IPO year
- 2021
- Market cap
- SEK 81.5M
- Website
- https://pilapharma.com
Loading PILA…
Loading profile data…Frequently asked questions about PILA
What does Pila Pharma AB (publ) (PILA.ST) do?
PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes. PILA PHARMA AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
Where does PILA.ST trade?
Pila Pharma AB (publ) (PILA.ST) trades on the Stockholm Stock Exchange.
What sector is PILA.ST in?
Pila Pharma AB (publ) (PILA.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pila Pharma AB (publ)?
Gustav Hanghoj Gram is the chief executive officer of Pila Pharma AB (publ) (PILA.ST).
Where is Pila Pharma AB (publ) headquartered?
Pila Pharma AB (publ) is headquartered in Sweden.
Does PILA.ST pay a dividend?
Pila Pharma AB (publ) (PILA.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PILA.ST go public?
Pila Pharma AB (publ) (PILA.ST) completed its initial public offering in 2021.